These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 745812)

  • 21. [Thyroid cancer risk from iodine-131-treatment? (author's transl)].
    Creutzig H; Hundeshagen H
    Med Klin; 1977 May; 72(19):855-7. PubMed ID: 865388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer incidence following treatment of hyperthyroidism.
    Hoffman DA; McConahey WM; Fraumeni JF; Kurland LT
    Int J Epidemiol; 1982 Sep; 11(3):218-24. PubMed ID: 7129736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Papillary adenocarcinoma of the thyroid developing after treatment of hyperthyroidism with 131I.
    Araki M; Oshiro K
    Gan; 1970 Jun; 61(3):267-9. PubMed ID: 5455326
    [No Abstract]   [Full Text] [Related]  

  • 24. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer in iodine-131 exposed patients.
    Hall P; Holm LE
    J Endocrinol Invest; 1995 Feb; 18(2):147-9. PubMed ID: 7629384
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of hyperthyroidism.
    Crile G
    World J Surg; 1978 May; 2(3):279-80. PubMed ID: 581319
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Cancer risk after iodine-131 therapy for hyperthyroidism.
    Meyer MA
    J Natl Cancer Inst; 1994 Jul; 86(13):1026-7. PubMed ID: 8007013
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk of thyroid cancer after exposure to 131I in childhood.
    Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
    J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer following iodine-131 therapy for hyperthyroidism.
    Hoffman DA; McConahey WM
    J Natl Cancer Inst; 1983 Jan; 70(1):63-7. PubMed ID: 6571923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid tumors following 131I or localized X irradiation to the thyroid and pituitary glands in rats.
    Lee W; Chiacchierini RP; Shleien B; Telles NC
    Radiat Res; 1982 Nov; 92(2):307-19. PubMed ID: 7163481
    [No Abstract]   [Full Text] [Related]  

  • 31. [There is no increased risk of thyroid cancer after diagnostic doses of 131I].
    Holm LE; Ericsson UB; Wiklund K; Larsson LG; Lundell G; Lidberg M; Bergman A; Lindberg S; Bjelkengren G; Wicklund H
    Lakartidningen; 1989 Aug; 86(35):2864-6. PubMed ID: 2796466
    [No Abstract]   [Full Text] [Related]  

  • 32. Aetiological consideration of thyroid carcinoma.
    Doniach I
    Monogr Neoplast Dis Var Sites; 1970; 6():55-72. PubMed ID: 4950412
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter: Thyroid cancer after iodine-131 therapy.
    McDougall IR
    JAMA; 1974 Jan; 227(4):438. PubMed ID: 4859683
    [No Abstract]   [Full Text] [Related]  

  • 34. Potassium iodide: effectiveness after nuclear accidents.
    Yalow RS
    Science; 1982 Nov; 218(4574):742. PubMed ID: 7134970
    [No Abstract]   [Full Text] [Related]  

  • 35. Cancer risks after diagnostic doses of 131I with special reference to thyroid cancer.
    Holm LE
    Cancer Detect Prev; 1991; 15(1):27-30. PubMed ID: 2044071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changes in the thyroid gland after irradiation with 131I or partial thyroidectomy for thyrotoxicosis.
    Kennedy JS; Thomson JA
    J Pathol; 1974 Feb; 112(2):65-81. PubMed ID: 4834051
    [No Abstract]   [Full Text] [Related]  

  • 37. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
    Huysmans DA; Buijs WC; van de Ven MT; van den Broek WJ; Kloppenborg PW; Hermus AR; Corstens FH
    J Nucl Med; 1996 Dec; 37(12):2072-9. PubMed ID: 8970537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.
    Dewji S; Bellamy M; Hertel N; Leggett R; Sherbini S; Saba M; Eckerman K
    Med Phys; 2015 Apr; 42(4):1851-7. PubMed ID: 25832075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.
    Yoosufani Z; Slavin JD; Hellman RM; Sethi SS; Spencer RP
    J Nucl Med; 1987 Aug; 28(8):1348-50. PubMed ID: 3612295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.